Dr. Erik E. Davydov, MD

Dr. Davydov practices at Facey Endoscopy Center in Mission Hills, California.

Dr. Davydov's NPI, 1336173582, was assigned on July 11, 2006. Dr. Davydov graduated from The Warren Alpert Medical School of Brown University in 1997. Dr. Davydov holds California license A066006.

Dr. Davydov's primary practice is Facey Endoscopy Center, at 11333 Sepulveda Blvd, #3200, Mission Hills, CA 91345. The practice phone is (818) 837-5776.

Dr. Davydov's primary practice is Facey Endoscopy Center in Mission Hills, California. Dr. Davydov is also affiliated with Providence Holy Cross Medical Center. The medical group on file is Facey Medical Group. Dr. Davydov's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davydov practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Davydov's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Davydov is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Davydov's licenses on file in 2 states: California and Texas.

Dmand AI lists aneurysm, aortic atherosclerois, arthritis, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic kidney disease and fibromyalgia and chronic pain among the conditions Dr. Davydov treats.

CMS data shows 1,177 Medicare services from Dr. Davydov across 10 procedure codes in 2024, for 477 Medicare patients. Medicare paid $31,157 for them.

CMS counts 477 Medicare patients who saw Dr. Davydov in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Davydov's median patient age at 68, with 50% women.

In 2024, Dr. Davydov wrote 4,580 Medicare Part D claims for 378 patients. 89% of them were for generic drugs. CMS names the drug for 3,904 of them, across 79 drugs with 11 or more claims each, at $280,575 in total drug cost. In 2023, CMS named 4,085 claims across 87 drugs.

Dr. Davydov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Davydov as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 146 general payments to Dr. Davydov from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Pfizer Inc. paid the most, $14,993.

Dmand AI lists 1 award for Dr. Davydov, most recently CMS Stage 1 2012 in 2011.

Dr. Davydov graduated from The Warren Alpert Medical School of Brown University in 1997.

Dr. Davydov is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.